Company intelligence / Profile preview

Aneira Health

Ownership: Private
Development stage: Preclinical

Overview

Aneira Health has launched a precision medicine platform that combines clinical care with advanced diagnostics—including blood biomarkers and genetic analysis—supported by proprietary AI models. The company aims to address diagnostic bias and data gaps in women's healthcare. Early results focus on comprehensive baseline assessments to inform personalized recommendations; no specific clinical trial outcomes are reported yet.

Therapeutic areas: Women's HealthEndocrinology
Modalities: Digital health platformAdvanced diagnosticsGenetic analysisBlood biomarker testingMachine learning/AI-driven insights
Industry: Molecular Diagnostics

Partnerships

Partners with clinicians, researchers, health systems, biotech companiesSignatory to Kearney [w]Health open letter community of >300 organizations focused on transforming women’s health.

Beyond the preview

Go deeper on Aneira Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aneira Health.

Explore the full profile